The search for a cure for retinopathy of prematurity (ROP) has become a priority among researchers since the disease was first described by Theodore L. Terry in 1942 . ROP is a common disorder, and the risk of visual impairment can be minimized in the vast majority of affected infants with careful management. Despite this, it is estimated that ROP accounts for 19% of cases of pediatric blindness worldwide  and is a leading cause of blindness in children attending schools for the blind [63, 66]. Continued interest in understanding and eradicating the disorder has brought about unprecedented collaboration among scientists, ophthalmologists, and public health activists in both developed and developing nations.
|Original language||English (US)|
|Title of host publication||Pediatric Ophthalmology|
|Subtitle of host publication||Current Thought and A Practical Guide|
|Publisher||Springer Berlin Heidelberg|
|Number of pages||12|
|State||Published - Dec 1 2009|
ASJC Scopus subject areas